{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T17:42:51Z","timestamp":1793727771833,"version":"4.6.1"},"reference-count":136,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cytokine & Growth Factor Reviews"],"published-print":{"date-parts":[[2022,10]]},"DOI":"10.1016\/j.cytogfr.2022.06.004","type":"journal-article","created":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T21:28:48Z","timestamp":1656710928000},"page":"66-79","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":45,"special_numbering":"C","title":["The IL-2A receptor pathway and its role in lymphocyte differentiation and function"],"prefix":"10.1016","volume":"67","author":[{"given":"Yuqian","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xue","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaokun","family":"Geng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haiping","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.cytogfr.2022.06.004_bib1","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0019038","article-title":"Continuous activation of the CD122\/STAT-5 signaling pathway during selection of antigen-specific regulatory T cells in the murine thymus","volume":"6","author":"Goldstein","year":"2011","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.cytogfr.2022.06.004_bib2","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1111\/j.1600-065X.2011.01004.x","article-title":"T-cell tolerance and the multi-functional role of IL-2R signaling in T-regulatory cells","volume":"241","author":"Cheng","year":"2011","journal-title":"Immunol. Rev."},{"issue":"11","key":"10.1016\/j.cytogfr.2022.06.004_bib3","doi-asserted-by":"crossref","first-page":"6426","DOI":"10.4049\/jimmunol.0903940","article-title":"Cutting edge: mechanisms of IL-2-dependent maintenance of functional regulatory T cells","volume":"185","author":"Barron","year":"2010","journal-title":"J. Immunol."},{"key":"10.1016\/j.cytogfr.2022.06.004_bib4","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1146\/annurev.immunol.26.021607.090357","article-title":"The biology of interleukin-2","volume":"26","author":"Malek","year":"2008","journal-title":"Annu Rev. Immunol."},{"issue":"2","key":"10.1016\/j.cytogfr.2022.06.004_bib5","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.immuni.2010.08.004","article-title":"Interleukin-2 receptor signaling: at the interface between tolerance and immunity","volume":"33","author":"Malek","year":"2010","journal-title":"Immunity"},{"issue":"3","key":"10.1016\/j.cytogfr.2022.06.004_bib6","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/j.immuni.2007.02.009","article-title":"Interleukin-2 signaling via STAT5 constrains T helper 17 cell generation","volume":"26","author":"Laurence","year":"2007","journal-title":"Immunity"},{"issue":"6","key":"10.1016\/j.cytogfr.2022.06.004_bib7","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1038\/ni.2030","article-title":"Modulation of cytokine receptors by IL-2 broadly regulates differentiation into helper T cell lineages","volume":"12","author":"Liao","year":"2011","journal-title":"Nat. Immunol."},{"issue":"11","key":"10.1016\/j.cytogfr.2022.06.004_bib8","doi-asserted-by":"crossref","first-page":"7445","DOI":"10.4049\/jimmunol.181.11.7445","article-title":"Cutting edge: CD4+ T cell-derived IL-2 is essential for help-dependent primary CD8+ T cell responses","volume":"181","author":"Wilson","year":"2008","journal-title":"J. Immunol."},{"key":"10.1016\/j.cytogfr.2022.06.004_bib9","doi-asserted-by":"crossref","DOI":"10.1016\/j.clim.2020.108515","article-title":"The IL-2 - IL-2 receptor pathway in health and disease: The role of the soluble IL-2 receptor","volume":"218","author":"Damoiseaux","year":"2020","journal-title":"Clin. Immunol."},{"issue":"1","key":"10.1016\/j.cytogfr.2022.06.004_bib10","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.immuni.2013.01.004","article-title":"Interleukin-2 at the crossroads of effector responses, tolerance, and immunotherapy","volume":"38","author":"Liao","year":"2013","journal-title":"Immunity"},{"issue":"1","key":"10.1016\/j.cytogfr.2022.06.004_bib11","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1111\/j.1365-2249.2007.03464.x","article-title":"Soluble interleukin-2 receptor and metalloproteinase-9 expression in head and neck cancer: prognostic value and analysis of their relationships","volume":"150","author":"El Houda Agueznay","year":"2007","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.cytogfr.2022.06.004_bib12","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1111\/j.0105-2896.2004.00203.x","article-title":"Cytokines and immunodeficiency diseases: critical roles of the gamma(c)-dependent cytokines interleukins 2, 4, 7, 9, 15, and 21, and their signaling pathways","volume":"202","author":"Kovanen","year":"2004","journal-title":"Immunol. Rev."},{"issue":"12","key":"10.1016\/j.cytogfr.2022.06.004_bib13","doi-asserted-by":"crossref","first-page":"3841","DOI":"10.4049\/jimmunol.137.12.3841","article-title":"The released interleukin 2 receptor binds interleukin 2 efficiently","volume":"137","author":"Rubin","year":"1986","journal-title":"J. Immunol."},{"issue":"1","key":"10.1016\/j.cytogfr.2022.06.004_bib14","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.jaut.2008.03.002","article-title":"The regulatory, inflammatory, and T cell programming roles of interleukin-2 (IL-2)","volume":"31","author":"Lan","year":"2008","journal-title":"J. Autoimmun."},{"issue":"5","key":"10.1016\/j.cytogfr.2022.06.004_bib15","doi-asserted-by":"crossref","first-page":"1878","DOI":"10.1073\/pnas.94.5.1878","article-title":"Requirement for an initial signal from the membrane-proximal region of the interleukin 2 receptor gamma(c) chain for Janus kinase activation leading to T cell proliferation","volume":"94","author":"Nelson","year":"1997","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"7395","key":"10.1016\/j.cytogfr.2022.06.004_bib16","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1038\/nature10975","article-title":"Exploiting a natural conformational switch to engineer an interleukin-2 'superkine'","volume":"484","author":"Levin","year":"2012","journal-title":"Nature"},{"issue":"5769","key":"10.1016\/j.cytogfr.2022.06.004_bib17","doi-asserted-by":"crossref","first-page":"1924","DOI":"10.1126\/science.1122927","article-title":"Selective stimulation of T cell subsets with antibody-cytokine immune complexes","volume":"311","author":"Boyman","year":"2006","journal-title":"Science"},{"issue":"8","key":"10.1016\/j.cytogfr.2022.06.004_bib18","doi-asserted-by":"crossref","first-page":"2788","DOI":"10.1073\/pnas.0511161103","article-title":"Crystal structure of the IL-2 signaling complex: paradigm for a heterotrimeric cytokine receptor","volume":"103","author":"Stauber","year":"2006","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"5751","key":"10.1016\/j.cytogfr.2022.06.004_bib19","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1126\/science.1117893","article-title":"Structure of the quaternary complex of interleukin-2 with its alpha, beta, and gammac receptors","volume":"310","author":"Wang","year":"2005","journal-title":"Science"},{"issue":"3","key":"10.1016\/j.cytogfr.2022.06.004_bib20","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1038\/nri3156","article-title":"The role of interleukin-2 during homeostasis and activation of the immune system","volume":"12","author":"Boyman","year":"2012","journal-title":"Nat. Rev. Immunol."},{"issue":"9","key":"10.1016\/j.cytogfr.2022.06.004_bib21","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1038\/nri1435","article-title":"Tolerance, not immunity, crucially depends on IL-2","volume":"4","author":"Malek","year":"2004","journal-title":"Nat. Rev. Immunol."},{"issue":"5987","key":"10.1016\/j.cytogfr.2022.06.004_bib22","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1038\/311626a0","article-title":"Molecular cloning and expression of cDNAs for the human interleukin-2 receptor","volume":"311","author":"Leonard","year":"1984","journal-title":"Nature"},{"issue":"5987","key":"10.1016\/j.cytogfr.2022.06.004_bib23","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1038\/311631a0","article-title":"Molecular cloning of cDNA encoding human interleukin-2 receptor","volume":"311","author":"Nikaido","year":"1984","journal-title":"Nature"},{"issue":"5727","key":"10.1016\/j.cytogfr.2022.06.004_bib24","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1126\/science.1109745","article-title":"The structure of interleukin-2 complexed with its alpha receptor","volume":"308","author":"Rickert","year":"2005","journal-title":"Science"},{"issue":"1","key":"10.1016\/j.cytogfr.2022.06.004_bib25","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1038\/s41590-017-0001-2","article-title":"Single-cell analysis reveals the continuum of human lympho-myeloid progenitor cells","volume":"19","author":"Karamitros","year":"2018","journal-title":"Nat. Immunol."},{"issue":"1","key":"10.1016\/j.cytogfr.2022.06.004_bib26","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.ccr.2010.12.012","article-title":"Coexistence of LMPP-like and GMP-like leukemia stem cells in acute myeloid leukemia","volume":"19","author":"Goardon","year":"2011","journal-title":"Cancer Cell"},{"issue":"7","key":"10.1016\/j.cytogfr.2022.06.004_bib27","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1038\/ni.1889","article-title":"Revised map of the human progenitor hierarchy shows the origin of macrophages and dendritic cells in early lymphoid development","volume":"11","author":"Doulatov","year":"2010","journal-title":"Nat. Immunol."},{"issue":"3","key":"10.1016\/j.cytogfr.2022.06.004_bib28","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1084\/jem.20141442","article-title":"Restricted dendritic cell and monocyte progenitors in human cord blood and bone marrow","volume":"212","author":"Lee","year":"2015","journal-title":"J. Exp. Med."},{"issue":"1","key":"10.1016\/j.cytogfr.2022.06.004_bib29","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1084\/jem.20131142","article-title":"CCR7 provides localized access to IL-2 and defines homeostatically distinct regulatory T cell subsets","volume":"211","author":"Smigiel","year":"2014","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.cytogfr.2022.06.004_bib30","doi-asserted-by":"crossref","first-page":"19182","DOI":"10.1038\/srep19182","article-title":"Regulation of asymmetric division by atypical protein kinase C influences early specification of CD8(+) T lymphocyte fates","volume":"6","author":"Metz","year":"2016","journal-title":"Sci. Rep."},{"issue":"13","key":"10.1016\/j.cytogfr.2022.06.004_bib31","doi-asserted-by":"crossref","first-page":"6298","DOI":"10.1073\/pnas.1812471116","article-title":"Microenvironment tailors nTreg structure and function","volume":"116","author":"Schiavon","year":"2019","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"9","key":"10.1016\/j.cytogfr.2022.06.004_bib32","doi-asserted-by":"crossref","first-page":"3665","DOI":"10.4049\/jimmunol.1500595","article-title":"Developmental progression and interrelationship of central and effector regulatory t cell subsets","volume":"196","author":"Toomer","year":"2016","journal-title":"J. Immunol."},{"issue":"8","key":"10.1016\/j.cytogfr.2022.06.004_bib33","first-page":"4489","article-title":"The roles of ZFAT in thymocyte differentiation and homeostasis of peripheral naive T-cells","volume":"34","author":"Doi","year":"2014","journal-title":"Anticancer Res"},{"issue":"5","key":"10.1016\/j.cytogfr.2022.06.004_bib34","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1002\/hep.21385","article-title":"IL-2 receptor alpha(-\/-) mice and the development of primary biliary cirrhosis","volume":"44","author":"Wakabayashi","year":"2006","journal-title":"Hepatology"},{"issue":"7","key":"10.1016\/j.cytogfr.2022.06.004_bib35","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1038\/s41590-020-0694-5","article-title":"Foxp3: a genetic foundation for regulatory T cell differentiation and function","volume":"21","author":"Ramsdell","year":"2020","journal-title":"Nat. Immunol."},{"issue":"11","key":"10.1016\/j.cytogfr.2022.06.004_bib36","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1038\/ni1263","article-title":"A function for interleukin 2 in Foxp3-expressing regulatory T cells","volume":"6","author":"Fontenot","year":"2005","journal-title":"Nat. Immunol."},{"issue":"11","key":"10.1016\/j.cytogfr.2022.06.004_bib37","doi-asserted-by":"crossref","first-page":"6519","DOI":"10.4049\/jimmunol.172.11.6519","article-title":"Cutting edge: IL-2 is critically required for the in vitro activation of CD4+CD25+ T cell suppressor function","volume":"172","author":"Thornton","year":"2004","journal-title":"J. Immunol."},{"issue":"1","key":"10.1016\/j.cytogfr.2022.06.004_bib38","doi-asserted-by":"crossref","first-page":"21994","DOI":"10.1038\/s41598-020-78975-y","article-title":"T cell signaling and Treg dysfunction correlate to disease kinetics in IL-2Ralpha-KO autoimmune mice","volume":"10","author":"Mullins","year":"2020","journal-title":"Sci. Rep."},{"issue":"6","key":"10.1016\/j.cytogfr.2022.06.004_bib39","doi-asserted-by":"crossref","first-page":"2445","DOI":"10.4049\/jimmunol.1601453","article-title":"IL-2 modulates the TCR signaling threshold for CD8 but not CD4 T cell proliferation on a single-cell level","volume":"198","author":"Au-Yeung","year":"2017","journal-title":"J. Immunol."},{"issue":"7","key":"10.1016\/j.cytogfr.2022.06.004_bib40","doi-asserted-by":"crossref","first-page":"1817","DOI":"10.1002\/eji.200737101","article-title":"IL-2Rbeta links IL-2R signaling with Foxp3 expression","volume":"37","author":"Soper","year":"2007","journal-title":"Eur. J. Immunol."},{"issue":"7","key":"10.1016\/j.cytogfr.2022.06.004_bib41","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1084\/jem.20101156","article-title":"PI3 kinase signalling blocks Foxp3 expression by sequestering Foxo factors","volume":"207","author":"Merkenschlager","year":"2010","journal-title":"J. Exp. Med"},{"issue":"2","key":"10.1016\/j.cytogfr.2022.06.004_bib42","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.it.2012.11.002","article-title":"Differentiation and function of Foxp3(+) effector regulatory T cells","volume":"34","author":"Cretney","year":"2013","journal-title":"Trends Immunol."},{"issue":"11","key":"10.1016\/j.cytogfr.2022.06.004_bib43","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1038\/ni.3004","article-title":"Continuous requirement for the TCR in regulatory T cell function","volume":"15","author":"Levine","year":"2014","journal-title":"Nat. Immunol."},{"issue":"5","key":"10.1016\/j.cytogfr.2022.06.004_bib44","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1016\/j.immuni.2014.10.012","article-title":"Continuous T cell receptor signals maintain a functional regulatory T cell pool","volume":"41","author":"Vahl","year":"2014","journal-title":"Immunity"},{"issue":"4","key":"10.1016\/j.cytogfr.2022.06.004_bib45","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1038\/ni.2006","article-title":"The transcription factors Blimp-1 and IRF4 jointly control the differentiation and function of effector regulatory T cells","volume":"12","author":"Cretney","year":"2011","journal-title":"Nat. Immunol."},{"issue":"3","key":"10.1016\/j.cytogfr.2022.06.004_bib46","doi-asserted-by":"crossref","first-page":"694","DOI":"10.4049\/jimmunol.1701151","article-title":"Expression of a functional IL-2 receptor in vascular smooth muscle cells","volume":"202","author":"Arumugam","year":"2019","journal-title":"J. Immunol."},{"issue":"9","key":"10.1016\/j.cytogfr.2022.06.004_bib47","first-page":"2521","article-title":"PTEN inhibits IL-2 receptor-mediated expansion of CD4+ CD25+ Tregs","volume":"116","author":"Walsh","year":"2006","journal-title":"J. Clin. Invest"},{"issue":"7587","key":"10.1016\/j.cytogfr.2022.06.004_bib48","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1038\/nature16486","article-title":"Graded Foxo1 activity in Treg cells differentiates tumour immunity from spontaneous autoimmunity","volume":"529","author":"Luo","year":"2016","journal-title":"Nature"},{"issue":"6","key":"10.1016\/j.cytogfr.2022.06.004_bib49","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1016\/j.immuni.2009.03.019","article-title":"Functional delineation and differentiation dynamics of human CD4+ T cells expressing the FoxP3 transcription factor","volume":"30","author":"Miyara","year":"2009","journal-title":"Immunity"},{"issue":"9","key":"10.1016\/j.cytogfr.2022.06.004_bib50","doi-asserted-by":"crossref","DOI":"10.1084\/jem.20190711","article-title":"BACH2 drives quiescence and maintenance of resting Treg cells to promote homeostasis and cancer immunosuppression","volume":"217","author":"Grant","year":"2020","journal-title":"J. Exp. Med"},{"issue":"6","key":"10.1016\/j.cytogfr.2022.06.004_bib51","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2021.109096","article-title":"Bach2 attenuates IL-2R signaling to control Treg homeostasis and Tfr development","volume":"35","author":"Zhang","year":"2021","journal-title":"Cell Rep."},{"issue":"3","key":"10.1016\/j.cytogfr.2022.06.004_bib52","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1111\/j.1478-3231.1999.tb00038.x","article-title":"Hepatic stellate cell activation and liver fibrosis are associated with necroinflammatory injury and Th1-like response in chronic hepatitis C","volume":"19","author":"Baroni","year":"1999","journal-title":"Liver"},{"issue":"2","key":"10.1016\/j.cytogfr.2022.06.004_bib53","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1046\/j.1365-3024.2001.00368.x","article-title":"A heart-specific CD4+ T-cell line obtained from a chronic chagasic mouse induces carditis in heart-immunized mice and rejection of normal heart transplants in the absence of Trypanosoma cruzi","volume":"23","author":"Ribeiro-Dos-Santos","year":"2001","journal-title":"Parasite Immunol."},{"issue":"11","key":"10.1016\/j.cytogfr.2022.06.004_bib54","doi-asserted-by":"crossref","first-page":"5300","DOI":"10.4049\/jimmunol.160.11.5300","article-title":"Macrophages induce cellular immunity by activating Th1 cell responses and suppressing Th2 cell responses","volume":"160","author":"Desmedt","year":"1998","journal-title":"J. Immunol."},{"issue":"4","key":"10.1016\/j.cytogfr.2022.06.004_bib55","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1007\/s00011-006-0067-z","article-title":"The antioxidants curcumin and quercetin inhibit inflammatory processes associated with arthritis","volume":"55","author":"Jackson","year":"2006","journal-title":"Inflamm. Res."},{"issue":"2","key":"10.1016\/j.cytogfr.2022.06.004_bib56","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1038\/ni1424","article-title":"Transcription factors T-bet and Runx3 cooperate to activate Ifng and silence Il4 in T helper type 1 cells","volume":"8","author":"Djuretic","year":"2007","journal-title":"Nat. Immunol."},{"issue":"5708","key":"10.1016\/j.cytogfr.2022.06.004_bib57","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1126\/science.1103336","article-title":"T helper cell fate specified by kinase-mediated interaction of T-bet with GATA-3","volume":"307","author":"Hwang","year":"2005","journal-title":"Science"},{"issue":"1","key":"10.1016\/j.cytogfr.2022.06.004_bib58","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.bcp.2008.03.020","article-title":"Regulatory mechanisms of IL-2 and IFNgamma suppression by quercetin in T helper cells","volume":"76","author":"Yu","year":"2008","journal-title":"Biochem Pharm."},{"issue":"2","key":"10.1016\/j.cytogfr.2022.06.004_bib59","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1189\/jlb.1112581","article-title":"CD4 T cell-intrinsic IL-2 signaling differentially affects Th1 and Th17 development","volume":"94","author":"Fujimura","year":"2013","journal-title":"J. Leukoc. Biol."},{"issue":"10","key":"10.1016\/j.cytogfr.2022.06.004_bib60","doi-asserted-by":"crossref","first-page":"5973","DOI":"10.4049\/jimmunol.172.10.5973","article-title":"IL-2 induces a competitive survival advantage in T lymphocytes","volume":"172","author":"Dooms","year":"2004","journal-title":"J. Immunol."},{"issue":"2","key":"10.1016\/j.cytogfr.2022.06.004_bib61","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1084\/jem.187.2.225","article-title":"A natural immunological adjuvant enhances T cell clonal expansion through a CD28-dependent, interleukin (IL)-2-independent mechanism","volume":"187","author":"Khoruts","year":"1998","journal-title":"J. Exp. Med"},{"issue":"7095","key":"10.1016\/j.cytogfr.2022.06.004_bib62","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1038\/nature04790","article-title":"Interleukin-2 signals during priming are required for secondary expansion of CD8+ memory T cells","volume":"441","author":"Williams","year":"2006","journal-title":"Nature"},{"issue":"9","key":"10.1016\/j.cytogfr.2022.06.004_bib63","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1038\/ni.2079","article-title":"Autocrine IL-2 is required for secondary population expansion of CD8(+) memory T cells","volume":"12","author":"Feau","year":"2011","journal-title":"Nat. Immunol."},{"issue":"26","key":"10.1016\/j.cytogfr.2022.06.004_bib64","doi-asserted-by":"crossref","first-page":"15137","DOI":"10.1073\/pnas.261570598","article-title":"T-bet is rapidly induced by interferon-gamma in lymphoid and myeloid cells","volume":"98","author":"Lighvani","year":"2001","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"1","key":"10.1016\/j.cytogfr.2022.06.004_bib65","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1073\/pnas.0909945107","article-title":"CD4+ T cell regulation of CD25 expression controls development of short-lived effector CD8+ T cells in primary and secondary responses","volume":"107","author":"Obar","year":"2010","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"1","key":"10.1016\/j.cytogfr.2022.06.004_bib66","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.immuni.2009.11.012","article-title":"Interleukin-2 and inflammation induce distinct transcriptional programs that promote the differentiation of effector cytolytic T cells","volume":"32","author":"Pipkin","year":"2010","journal-title":"Immunity"},{"issue":"2","key":"10.1016\/j.cytogfr.2022.06.004_bib67","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.immuni.2007.07.010","article-title":"Inflammation directs memory precursor and short-lived effector CD8(+) T cell fates via the graded expression of T-bet transcription factor","volume":"27","author":"Joshi","year":"2007","journal-title":"Immunity"},{"issue":"2","key":"10.1016\/j.cytogfr.2022.06.004_bib68","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0089010","article-title":"Inflammation enhances IL-2 driven differentiation of cytolytic CD4 T cells","volume":"9","author":"Workman","year":"2014","journal-title":"PLoS One"},{"issue":"5","key":"10.1016\/j.cytogfr.2022.06.004_bib69","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1016\/S1074-7613(00)80566-X","article-title":"Biochemical mechanisms of IL-2-regulated Fas-mediated T cell apoptosis","volume":"8","author":"Refaeli","year":"1998","journal-title":"Immunity"},{"issue":"3","key":"10.1016\/j.cytogfr.2022.06.004_bib70","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.4049\/jimmunol.169.3.1270","article-title":"The CD154-CD40 T cell costimulation pathway is required for host sensitization of CD8(+) T cells by skin grafts via direct antigen presentation","volume":"169","author":"Zhai","year":"2002","journal-title":"J. Immunol."},{"issue":"1","key":"10.1016\/j.cytogfr.2022.06.004_bib71","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.immuni.2009.11.010","article-title":"Prolonged interleukin-2Ralpha expression on virus-specific CD8+ T cells favors terminal-effector differentiation in vivo","volume":"32","author":"Kalia","year":"2010","journal-title":"Immunity"},{"issue":"6684","key":"10.1016\/j.cytogfr.2022.06.004_bib72","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1038\/30996","article-title":"Help for cytotoxic-T-cell responses is mediated by CD40 signalling","volume":"393","author":"Bennett","year":"1998","journal-title":"Nature"},{"issue":"6684","key":"10.1016\/j.cytogfr.2022.06.004_bib73","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1038\/31002","article-title":"T-cell help for cytotoxic T lymphocytes is mediated by CD40-CD40L interactions","volume":"393","author":"Schoenberger","year":"1998","journal-title":"Nature"},{"issue":"6","key":"10.1016\/j.cytogfr.2022.06.004_bib74","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1084\/jem.20031591","article-title":"Combined TLR and CD40 triggering induces potent CD8+ T cell expansion with variable dependence on type I IFN","volume":"199","author":"Ahonen","year":"2004","journal-title":"J. Exp. Med."},{"issue":"4","key":"10.1016\/j.cytogfr.2022.06.004_bib75","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1038\/ni.2842","article-title":"Early specification of CD8+ T lymphocyte fates during adaptive immunity revealed by single-cell gene-expression analyses","volume":"15","author":"Arsenio","year":"2014","journal-title":"Nat. Immunol."},{"issue":"4","key":"10.1016\/j.cytogfr.2022.06.004_bib76","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1016\/j.immuni.2011.03.017","article-title":"Asymmetric proteasome segregation as a mechanism for unequal partitioning of the transcription factor T-bet during T lymphocyte division","volume":"34","author":"Chang","year":"2011","journal-title":"Immunity"},{"issue":"5819","key":"10.1016\/j.cytogfr.2022.06.004_bib77","doi-asserted-by":"crossref","first-page":"1687","DOI":"10.1126\/science.1139393","article-title":"Asymmetric T lymphocyte division in the initiation of adaptive immune responses","volume":"315","author":"Chang","year":"2007","journal-title":"Science"},{"issue":"1","key":"10.1016\/j.cytogfr.2022.06.004_bib78","doi-asserted-by":"crossref","first-page":"367","DOI":"10.4049\/jimmunol.0903627","article-title":"Asymmetric cell division of T cells upon antigen presentation uses multiple conserved mechanisms","volume":"185","author":"Oliaro","year":"2010","journal-title":"J. Immunol."},{"issue":"5","key":"10.1016\/j.cytogfr.2022.06.004_bib79","doi-asserted-by":"crossref","first-page":"2249","DOI":"10.4049\/jimmunol.1401652","article-title":"Regulation of asymmetric division and CD8+ T lymphocyte fate specification by protein kinase Czeta and protein kinase Clambda\/iota","volume":"194","author":"Metz","year":"2015","journal-title":"J. Immunol."},{"issue":"4","key":"10.1016\/j.cytogfr.2022.06.004_bib80","doi-asserted-by":"crossref","first-page":"1737","DOI":"10.4049\/jimmunol.1401082","article-title":"The inducible costimulator augments Tc17 cell responses to self and tumor tissue","volume":"194","author":"Nelson","year":"2015","journal-title":"J. Immunol."},{"issue":"5","key":"10.1016\/j.cytogfr.2022.06.004_bib81","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1084\/jem.20041982","article-title":"Homeostatic maintenance of natural Foxp3(+) CD25(+) CD4(+) regulatory T cells by interleukin (IL)-2 and induction of autoimmune disease by IL-2 neutralization","volume":"201","author":"Setoguchi","year":"2005","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.cytogfr.2022.06.004_bib82","doi-asserted-by":"crossref","first-page":"921","DOI":"10.2741\/1848","article-title":"Signal transduction in CD4+CD25+ regulatory T cells: CD25 and IL-2","volume":"11","author":"Thornton","year":"2006","journal-title":"Front Biosci."},{"issue":"2","key":"10.1016\/j.cytogfr.2022.06.004_bib83","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1038\/icb.2011.45","article-title":"Interleukin-2 is present in human blood vessels and released in biologically active form by heparanase","volume":"90","author":"Miller","year":"2012","journal-title":"Immunol. Cell Biol."},{"issue":"2","key":"10.1016\/j.cytogfr.2022.06.004_bib84","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1093\/rheumatology\/kep357","article-title":"Age-related T-cell cytokine profile parallels corneal disease severity in Sjogren's syndrome-like keratoconjunctivitis sicca in CD25KO mice","volume":"49","author":"De Paiva","year":"2010","journal-title":"Rheumatology"},{"issue":"11","key":"10.1016\/j.cytogfr.2022.06.004_bib85","doi-asserted-by":"crossref","first-page":"3053","DOI":"10.1002\/eji.1830251111","article-title":"Generalized autoimmune disease in interleukin-2-deficient mice is triggered by an uncontrolled activation and proliferation of CD4+ T cells","volume":"25","author":"Sadlack","year":"1995","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.cytogfr.2022.06.004_bib86","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.jaut.2016.07.007","article-title":"CD8(+) T cells drive autoimmune hematopoietic stem cell dysfunction and bone marrow failure","volume":"75","author":"Gravano","year":"2016","journal-title":"J. Autoimmun."},{"issue":"6","key":"10.1016\/j.cytogfr.2022.06.004_bib87","doi-asserted-by":"crossref","first-page":"R234","DOI":"10.1186\/ar4077","article-title":"Deletion of interferon-gamma delays onset and severity of dacryoadenitis in CD25KO mice","volume":"14","author":"Pelegrino","year":"2012","journal-title":"Arthritis Res Ther."},{"issue":"2","key":"10.1016\/j.cytogfr.2022.06.004_bib88","doi-asserted-by":"crossref","first-page":"744","DOI":"10.2353\/ajpath.2010.091116","article-title":"Spontaneous autoimmune dacryoadenitis in aged CD25KO mice","volume":"177","author":"Rahimy","year":"2010","journal-title":"Am. J. Pathol."},{"issue":"10","key":"10.1016\/j.cytogfr.2022.06.004_bib89","doi-asserted-by":"crossref","first-page":"5170","DOI":"10.4049\/jimmunol.1003961","article-title":"The basis of distinctive IL-2- and IL-15-dependent signaling: weak CD122-dependent signaling favors CD8+ T central-memory cell survival but not T effector-memory cell development","volume":"187","author":"Castro","year":"2011","journal-title":"J. Immunol."},{"issue":"4","key":"10.1016\/j.cytogfr.2022.06.004_bib90","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/1074-7613(95)90180-9","article-title":"Interleukin-2 receptor alpha chain regulates the size and content of the peripheral lymphoid compartment","volume":"3","author":"Willerford","year":"1995","journal-title":"Immunity"},{"issue":"4","key":"10.1016\/j.cytogfr.2022.06.004_bib91","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.jaut.2006.11.003","article-title":"Novel animal models for Sjogren\u2019s syndrome: expression and transfer of salivary gland dysfunction from regulatory T cell-deficient mice","volume":"27","author":"Sharma","year":"2006","journal-title":"J. Autoimmun."},{"issue":"29","key":"10.1016\/j.cytogfr.2022.06.004_bib92","doi-asserted-by":"crossref","first-page":"33782","DOI":"10.1021\/acsami.1c04827","article-title":"New tool for rapid and accurate detection of interleukin-2 and soluble interleukin-2 receptor alpha in cancer diagnosis using a bioresponsive microgel and multivalent protein binding","volume":"13","author":"Yang","year":"2021","journal-title":"ACS Appl. Mater. Interfaces"},{"issue":"21","key":"10.1016\/j.cytogfr.2022.06.004_bib93","doi-asserted-by":"crossref","first-page":"1981","DOI":"10.1056\/NEJMoa2001123","article-title":"Endovascular thrombectomy with or without intravenous alteplase in acute stroke","volume":"382","author":"Yang","year":"2020","journal-title":"New Engl. J. Med"},{"key":"10.1016\/j.cytogfr.2022.06.004_bib94","doi-asserted-by":"crossref","DOI":"10.1155\/2021\/9965850","article-title":"Predictive immunological, virological, and routine laboratory markers for critical COVID-19 on admission","volume":"2021","author":"Garcia-Gasalla","year":"2021","journal-title":"Can. J. Infect. Dis. Med Microbiol"},{"key":"10.1016\/j.cytogfr.2022.06.004_bib95","doi-asserted-by":"crossref","DOI":"10.1016\/j.cyto.2021.155438","article-title":"Interleukin 6, soluble interleukin 2 receptor alpha (CD25), monocyte colony-stimulating factor, and hepatocyte growth factor linked with systemic hyperinflammation, innate immunity hyperactivation, and organ damage in COVID-19 pneumonia","volume":"140","author":"Quartuccio","year":"2021","journal-title":"Cytokine"},{"key":"10.1016\/j.cytogfr.2022.06.004_bib96","doi-asserted-by":"crossref","DOI":"10.1016\/j.cyto.2021.155790","article-title":"Role of immune mediators in predicting hospitalization of SARS-CoV-2 positive patients","volume":"150","author":"Ashrafzadeh-Kian","year":"2022","journal-title":"Cytokine"},{"issue":"1","key":"10.1016\/j.cytogfr.2022.06.004_bib97","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1186\/s40249-020-00699-y","article-title":"Soluble IL-2Ralpha correlates with imbalances of Th1\/Th2 and Tc1\/Tc2 cells in patients with acute brucellosis","volume":"9","author":"Sun","year":"2020","journal-title":"Infect. Dis. Poverty"},{"issue":"2","key":"10.1016\/j.cytogfr.2022.06.004_bib98","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0031822","article-title":"Cytokine profiles, CTL response and T cell frequencies in the peripheral blood of acute patients and individuals recovered from hepatitis E infection","volume":"7","author":"Tripathy","year":"2012","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.cytogfr.2022.06.004_bib99","doi-asserted-by":"crossref","DOI":"10.3390\/v10010034","article-title":"Biomarkers of progression after HIV Acute\/Early infection: nothing compares to CD4(+) T-cell count?","volume":"10","author":"Turk","year":"2018","journal-title":"Viruses"},{"issue":"11","key":"10.1016\/j.cytogfr.2022.06.004_bib100","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1016\/j.jcyt.2021.06.003","article-title":"A biomarker-guided, prospective, phase 2 trial of pre-emptive graft-versus-host disease therapy using anti-thymocyte globulin","volume":"23","author":"Khanolkar","year":"2021","journal-title":"Cytotherapy"},{"issue":"1","key":"10.1016\/j.cytogfr.2022.06.004_bib101","first-page":"8","article-title":"Relationship between serum soluble interleukin-2 receptor and renal allograft rejection: a hospital-based study in Kashmirvalley","volume":"6","author":"Rasool","year":"2015","journal-title":"Int J. Organ Transpl. Med."},{"issue":"2","key":"10.1016\/j.cytogfr.2022.06.004_bib102","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1111\/j.1365-2710.2004.00547.x","article-title":"Influence of thyroxine on serum soluble interleukin-2 receptor alpha levels in thyroid disorders","volume":"29","author":"Zwirska-Korczala","year":"2004","journal-title":"J. Clin. Pharm. Ther."},{"key":"10.1016\/j.cytogfr.2022.06.004_bib103","doi-asserted-by":"crossref","DOI":"10.1093\/rheumatology\/keac178","article-title":"Soluble interleukin-2 receptor serum levels facilitate prediction of relapses in subgroups of patients with juvenile idiopathic arthritis","author":"Ziegler","year":"2022","journal-title":"Rheumatol. (Oxf. )"},{"issue":"12","key":"10.1016\/j.cytogfr.2022.06.004_bib104","doi-asserted-by":"crossref","first-page":"E223","DOI":"10.1002\/ajh.23838","article-title":"Elevated soluble IL-2Ralpha, IL-8, and MIP-1beta levels are associated with inferior outcome and are independent of MIPI score in patients with mantle cell lymphoma","volume":"89","author":"Sonbol","year":"2014","journal-title":"Am. J. Hematol."},{"key":"10.1016\/j.cytogfr.2022.06.004_bib105","doi-asserted-by":"crossref","DOI":"10.1210\/clinem\/dgac131","article-title":"sIL-2R: a novel diagnostic biomarker for primary adrenal lymphoma","author":"Yu","year":"2022","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.cytogfr.2022.06.004_bib106","doi-asserted-by":"crossref","DOI":"10.1016\/j.cyto.2020.155005","article-title":"Serum levels of selected cytokines and soluble adhesion molecules in acute myeloid leukemia: Soluble receptor for interleukin-2 predicts overall survival","volume":"128","author":"Kupsa","year":"2020","journal-title":"Cytokine"},{"issue":"1","key":"10.1016\/j.cytogfr.2022.06.004_bib107","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1186\/s12885-016-2945-2","article-title":"Phase I study of low-dose metronomic temozolomide for recurrent malignant gliomas","volume":"16","author":"Wong","year":"2016","journal-title":"BMC Cancer"},{"key":"10.1016\/j.cytogfr.2022.06.004_bib108","doi-asserted-by":"crossref","DOI":"10.1155\/2022\/4348063","article-title":"Pleural fluid soluble interleukin-2 receptor as a biomarker for the diagnosis of tuberculosis pleural effusion: a systematic review and meta-analysis","volume":"2022","author":"Yan","year":"2022","journal-title":"J. Trop. Med"},{"issue":"14","key":"10.1016\/j.cytogfr.2022.06.004_bib109","doi-asserted-by":"crossref","first-page":"4710","DOI":"10.1002\/cam4.3963","article-title":"Pivotal factors associated with the immunosuppressive tumor microenvironment and melanoma metastasis","volume":"10","author":"Zhang","year":"2021","journal-title":"Cancer Med."},{"issue":"17","key":"10.1016\/j.cytogfr.2022.06.004_bib110","doi-asserted-by":"crossref","first-page":"2236","DOI":"10.1002\/cbic.201900109","article-title":"A rapid colorimetric sensor for soluble interleukin-2 receptor alpha, based on aptamer-adsorbed AuNP","volume":"20","author":"Jeon","year":"2019","journal-title":"Chembiochem"},{"issue":"4","key":"10.1016\/j.cytogfr.2022.06.004_bib111","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0036316","article-title":"Soluble cytokine receptors (sIL-2Ralpha, sIL-2Rbeta) induce subunit-specific behavioral responses and accumulate in the cerebral cortex and basal forebrain","volume":"7","author":"Zalcman","year":"2012","journal-title":"PLoS One"},{"issue":"11","key":"10.1016\/j.cytogfr.2022.06.004_bib112","doi-asserted-by":"crossref","first-page":"1994","DOI":"10.1093\/aje\/kwz190","article-title":"Inflammation and risk of depression in HIV: prospective findings from the multicenter AIDS cohort study","volume":"188","author":"Lu","year":"2019","journal-title":"Am. J. Epidemiol."},{"key":"10.1016\/j.cytogfr.2022.06.004_bib113","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.bbi.2021.07.009","article-title":"Associations of immunological proteins\/traits with schizophrenia, major depression and bipolar disorder: a bi-directional two-sample mendelian randomization study","volume":"97","author":"Perry","year":"2021","journal-title":"Brain Behav. Immun."},{"issue":"8","key":"10.1016\/j.cytogfr.2022.06.004_bib114","doi-asserted-by":"crossref","first-page":"2403","DOI":"10.18632\/aging.101924","article-title":"Identification of inflammatory and vascular markers associated with mild cognitive impairment","volume":"11","author":"Shen","year":"2019","journal-title":"Aging (Albany NY)"},{"key":"10.1016\/j.cytogfr.2022.06.004_bib115","doi-asserted-by":"crossref","DOI":"10.1016\/j.msard.2021.103140","article-title":"Biomarkers of systemic inflammation, soluble IL-2Ralpha and the multiple sclerosis-associated IL2RA SNP rs2104286 in healthy subjects and multiple sclerosis patients","volume":"54","author":"Buhelt","year":"2021","journal-title":"Mult. Scler. Relat. Disord."},{"key":"10.1016\/j.cytogfr.2022.06.004_bib116","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.676141","article-title":"IL2RA methylation and gene expression in relation to the multiple sclerosis-associated gene variant rs2104286 and soluble IL-2ralpha in CD8(+) T cells","volume":"12","author":"Buhelt","year":"2021","journal-title":"Front Immunol."},{"key":"10.1016\/j.cytogfr.2022.06.004_bib117","doi-asserted-by":"crossref","DOI":"10.1016\/j.jneuroim.2021.577499","article-title":"NK\/T cell ratios associate with interleukin-2 receptor alpha chain expression and shedding in multiple sclerosis","volume":"353","author":"Mimpen","year":"2021","journal-title":"J. Neuroimmunol."},{"issue":"14","key":"10.1016\/j.cytogfr.2022.06.004_bib118","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1089\/neu.2019.6780","article-title":"Anti-pituitary and anti-hypothalamus autoantibody associations with inflammation and persistent hypogonadotropic hypogonadism in men with traumatic brain injury","volume":"37","author":"Vijapur","year":"2020","journal-title":"J. Neurotrauma"},{"issue":"10","key":"10.1016\/j.cytogfr.2022.06.004_bib119","doi-asserted-by":"crossref","first-page":"2246","DOI":"10.1161\/ATVBAHA.115.305289","article-title":"Plasma levels of soluble interleukin-2 receptor alpha: associations with clinical cardiovascular events and genome-wide association scan","volume":"35","author":"Durda","year":"2015","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"issue":"2","key":"10.1016\/j.cytogfr.2022.06.004_bib120","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1002\/ehf2.12623","article-title":"Association of soluble interleukin-2 receptor alpha and tumour necrosis factor receptor 1 with heart failure: The Multi-Ethnic Study of Atherosclerosis","volume":"7","author":"Bakhshi","year":"2020","journal-title":"ESC Heart Fail"},{"issue":"9","key":"10.1016\/j.cytogfr.2022.06.004_bib121","doi-asserted-by":"crossref","first-page":"8423","DOI":"10.18632\/aging.103149","article-title":"Inflammatory activation and endothelial dysfunction markers in patients with permanent atrial fibrillation: a cross-sectional study","volume":"12","author":"Maida","year":"2020","journal-title":"Aging (Albany NY)"},{"issue":"6","key":"10.1016\/j.cytogfr.2022.06.004_bib122","doi-asserted-by":"crossref","first-page":"5282","DOI":"10.1002\/ehf2.13614","article-title":"Association of high serum soluble interleukin 2 receptor levels with risk of adverse events in cardiac sarcoidosis","volume":"8","author":"Kobayashi","year":"2021","journal-title":"ESC Heart Fail"},{"issue":"5","key":"10.1016\/j.cytogfr.2022.06.004_bib123","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1536\/ihj.17-695","article-title":"A multiple biomarker approach in patients with cardiac sarcoidosis","volume":"59","author":"Kiko","year":"2018","journal-title":"Int Heart J."},{"issue":"2","key":"10.1016\/j.cytogfr.2022.06.004_bib124","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1002\/acr2.11366","article-title":"Serum biomarkers of disease activity in longitudinal assessment of patients with ANCA-associated vasculitis","volume":"4","author":"Monach","year":"2022","journal-title":"ACR Open Rheuma"},{"key":"10.1016\/j.cytogfr.2022.06.004_bib125","doi-asserted-by":"crossref","DOI":"10.1038\/s41577-022-00680-w","article-title":"Engineering IL-2 for immunotherapy of autoimmunity and cancer","author":"Hernandez","year":"2022","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.cytogfr.2022.06.004_bib126","article-title":"Facile discovery of surrogate cytokine agonists","author":"Yen","year":"2022","journal-title":"Cell"},{"key":"10.1016\/j.cytogfr.2022.06.004_bib127","doi-asserted-by":"crossref","DOI":"10.1039\/D1LC01098K","article-title":"Carlo, IL-2 secretion-based sorting of single T cells using high-throughput microfluidic on-cell cytokine capture","author":"Dimatteo","year":"2022","journal-title":"Lab Chip"},{"key":"10.1016\/j.cytogfr.2022.06.004_bib128","doi-asserted-by":"crossref","DOI":"10.3389\/fmolb.2022.777390","article-title":"Mathematical modeling of proliferative immune response initiated by interactions between classical antigen-presenting cells under joint antagonistic IL-2 and IL-4 signaling","volume":"9","author":"Atitey","year":"2022","journal-title":"Front Mol. Biosci."},{"issue":"1","key":"10.1016\/j.cytogfr.2022.06.004_bib129","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1080\/10837450.2021.2019764","article-title":"Controlled release of bioactive IL-2 from visible light photocured biodegradable elastomers for cancer immunotherapy applications","volume":"27","author":"Shaker","year":"2022","journal-title":"Pharm. Dev. Technol."},{"issue":"2","key":"10.1016\/j.cytogfr.2022.06.004_bib130","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0264353","article-title":"Human IL-2Ra subunit binding modulation of IL-2 through a decline in electrostatic interactions: a computational and experimental approach","volume":"17","author":"Beig Parikhani","year":"2022","journal-title":"PLoS One"},{"key":"10.1016\/j.cytogfr.2022.06.004_bib131","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2021.121257","article-title":"Nanoparticle delivery of recombinant IL-2 (BALLkine-2) achieves durable tumor control with less systemic adverse effects in cancer immunotherapy","volume":"280","author":"Kim","year":"2022","journal-title":"Biomaterials"},{"issue":"3","key":"10.1016\/j.cytogfr.2022.06.004_bib132","doi-asserted-by":"crossref","DOI":"10.1172\/JCI153604","article-title":"Selective delivery of low-affinity IL-2 to PD-1+ T cells rejuvenates antitumor immunity with reduced toxicity","volume":"132","author":"Ren","year":"2022","journal-title":"J. Clin. Invest"},{"issue":"3","key":"10.1016\/j.cytogfr.2022.06.004_bib133","doi-asserted-by":"crossref","DOI":"10.1172\/JCI156628","article-title":"A forced marriage of IL-2 and PD-1 antibody nurtures tumor-infiltrating T cells","volume":"132","author":"Holcomb","year":"2022","journal-title":"J. Clin. Invest"},{"key":"10.1016\/j.cytogfr.2022.06.004_bib134","doi-asserted-by":"crossref","DOI":"10.1016\/j.tranon.2022.101358","article-title":"IL-2 complex recovers steroid-induced inhibition in immunochemotherapy for head and neck cancer","volume":"18","author":"Kono","year":"2022","journal-title":"Transl. Oncol."},{"issue":"1","key":"10.1016\/j.cytogfr.2022.06.004_bib135","doi-asserted-by":"crossref","first-page":"5376","DOI":"10.1038\/s41598-022-09278-7","article-title":"Efficacy and antitumor activity of a mutant type of interleukin 2","volume":"12","author":"Dehghan","year":"2022","journal-title":"Sci. Rep."},{"issue":"3","key":"10.1016\/j.cytogfr.2022.06.004_bib136","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1111\/all.15029","article-title":"Engineering a safe monoclonal anti-human IL-2 that is effective in a murine model of food allergy and asthma","volume":"77","author":"Klein","year":"2022","journal-title":"Allergy"}],"container-title":["Cytokine & Growth Factor Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1359610122000491?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1359610122000491?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,23]],"date-time":"2025-10-23T11:00:34Z","timestamp":1761217234000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1359610122000491"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10]]},"references-count":136,"alternative-id":["S1359610122000491"],"URL":"https:\/\/doi.org\/10.1016\/j.cytogfr.2022.06.004","relation":{},"ISSN":["1359-6101"],"issn-type":[{"value":"1359-6101","type":"print"}],"subject":[],"published":{"date-parts":[[2022,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The IL-2A receptor pathway and its role in lymphocyte differentiation and function","name":"articletitle","label":"Article Title"},{"value":"Cytokine & Growth Factor Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cytogfr.2022.06.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}